Table of Content

1 S-Amlodipine Market Overview
1.1 Product Overview and Scope of S-Amlodipine
1.2 S-Amlodipine Segment by Type
1.2.1 Global S-Amlodipine Market Value Comparison by Type (2024-2034)
1.2.2 Amlodipine Besylate Tablets
1.2.3 Amlodipine Mesylate Tablets
1.2.4 Amlodipine Maleate Tablets
1.3 S-Amlodipine Segment by Application
1.3.1 Global S-Amlodipine Market Value by Application: (2024-2034)
1.3.2 Hypertension
1.3.3 Angina pectoris
1.4 Global S-Amlodipine Market Size Estimates and Forecasts
1.4.1 Global S-Amlodipine Revenue 2018-2034
1.4.2 Global S-Amlodipine Sales 2018-2034
1.4.3 Global S-Amlodipine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 S-Amlodipine Market Competition by Manufacturers
2.1 Global S-Amlodipine Sales Market Share by Manufacturers (2018-2023)
2.2 Global S-Amlodipine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global S-Amlodipine Average Price by Manufacturers (2018-2023)
2.4 Global S-Amlodipine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of S-Amlodipine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of S-Amlodipine, Product Type & Application
2.7 S-Amlodipine Market Competitive Situation and Trends
2.7.1 S-Amlodipine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest S-Amlodipine Players Market Share by Revenue
2.7.3 Global S-Amlodipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 S-Amlodipine Retrospective Market Scenario by Region
3.1 Global S-Amlodipine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global S-Amlodipine Global S-Amlodipine Sales by Region: 2018-2034
3.2.1 Global S-Amlodipine Sales by Region: 2018-2023
3.2.2 Global S-Amlodipine Sales by Region: 2024-2034
3.3 Global S-Amlodipine Global S-Amlodipine Revenue by Region: 2018-2034
3.3.1 Global S-Amlodipine Revenue by Region: 2018-2023
3.3.2 Global S-Amlodipine Revenue by Region: 2024-2034
3.4 North America S-Amlodipine Market Facts & Figures by Country
3.4.1 North America S-Amlodipine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America S-Amlodipine Sales by Country (2018-2034)
3.4.3 North America S-Amlodipine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe S-Amlodipine Market Facts & Figures by Country
3.5.1 Europe S-Amlodipine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe S-Amlodipine Sales by Country (2018-2034)
3.5.3 Europe S-Amlodipine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific S-Amlodipine Market Facts & Figures by Country
3.6.1 Asia Pacific S-Amlodipine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific S-Amlodipine Sales by Country (2018-2034)
3.6.3 Asia Pacific S-Amlodipine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America S-Amlodipine Market Facts & Figures by Country
3.7.1 Latin America S-Amlodipine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America S-Amlodipine Sales by Country (2018-2034)
3.7.3 Latin America S-Amlodipine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa S-Amlodipine Market Facts & Figures by Country
3.8.1 Middle East and Africa S-Amlodipine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa S-Amlodipine Sales by Country (2018-2034)
3.8.3 Middle East and Africa S-Amlodipine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global S-Amlodipine Sales by Type (2018-2034)
4.1.1 Global S-Amlodipine Sales by Type (2018-2023)
4.1.2 Global S-Amlodipine Sales by Type (2024-2034)
4.1.3 Global S-Amlodipine Sales Market Share by Type (2018-2034)
4.2 Global S-Amlodipine Revenue by Type (2018-2034)
4.2.1 Global S-Amlodipine Revenue by Type (2018-2023)
4.2.2 Global S-Amlodipine Revenue by Type (2024-2034)
4.2.3 Global S-Amlodipine Revenue Market Share by Type (2018-2034)
4.3 Global S-Amlodipine Price by Type (2018-2034)
5 Segment by Application
5.1 Global S-Amlodipine Sales by Application (2018-2034)
5.1.1 Global S-Amlodipine Sales by Application (2018-2023)
5.1.2 Global S-Amlodipine Sales by Application (2024-2034)
5.1.3 Global S-Amlodipine Sales Market Share by Application (2018-2034)
5.2 Global S-Amlodipine Revenue by Application (2018-2034)
5.2.1 Global S-Amlodipine Revenue by Application (2018-2023)
5.2.2 Global S-Amlodipine Revenue by Application (2024-2034)
5.2.3 Global S-Amlodipine Revenue Market Share by Application (2018-2034)
5.3 Global S-Amlodipine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Aristo Pharmaceuticals Pvt Ltd
6.1.1 Aristo Pharmaceuticals Pvt Ltd Corporation Information
6.1.2 Aristo Pharmaceuticals Pvt Ltd Description and Business Overview
6.1.3 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Portfolio
6.1.5 Aristo Pharmaceuticals Pvt Ltd Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis S-Amlodipine Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer S-Amlodipine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Lek
6.4.1 Lek Corporation Information
6.4.2 Lek Description and Business Overview
6.4.3 Lek S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lek S-Amlodipine Product Portfolio
6.4.5 Lek Recent Developments/Updates
6.5 TEVA
6.5.1 TEVA Corporation Information
6.5.2 TEVA Description and Business Overview
6.5.3 TEVA S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 TEVA S-Amlodipine Product Portfolio
6.5.5 TEVA Recent Developments/Updates
6.6 Macleods Pharmaceuticals
6.6.1 Macleods Pharmaceuticals Corporation Information
6.6.2 Macleods Pharmaceuticals Description and Business Overview
6.6.3 Macleods Pharmaceuticals S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Macleods Pharmaceuticals S-Amlodipine Product Portfolio
6.6.5 Macleods Pharmaceuticals Recent Developments/Updates
6.7 Caraco Pharmaceutical
6.6.1 Caraco Pharmaceutical Corporation Information
6.6.2 Caraco Pharmaceutical Description and Business Overview
6.6.3 Caraco Pharmaceutical S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Caraco Pharmaceutical S-Amlodipine Product Portfolio
6.7.5 Caraco Pharmaceutical Recent Developments/Updates
6.8 Sanis Health
6.8.1 Sanis Health Corporation Information
6.8.2 Sanis Health Description and Business Overview
6.8.3 Sanis Health S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sanis Health S-Amlodipine Product Portfolio
6.8.5 Sanis Health Recent Developments/Updates
6.9 Jamp Pharma
6.9.1 Jamp Pharma Corporation Information
6.9.2 Jamp Pharma Description and Business Overview
6.9.3 Jamp Pharma S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jamp Pharma S-Amlodipine Product Portfolio
6.9.5 Jamp Pharma Recent Developments/Updates
6.10 Accel Pharma
6.10.1 Accel Pharma Corporation Information
6.10.2 Accel Pharma Description and Business Overview
6.10.3 Accel Pharma S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Accel Pharma S-Amlodipine Product Portfolio
6.10.5 Accel Pharma Recent Developments/Updates
6.11 Jubilant Generics
6.11.1 Jubilant Generics Corporation Information
6.11.2 Jubilant Generics S-Amlodipine Description and Business Overview
6.11.3 Jubilant Generics S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jubilant Generics S-Amlodipine Product Portfolio
6.11.5 Jubilant Generics Recent Developments/Updates
6.12 Angita Pharma
6.12.1 Angita Pharma Corporation Information
6.12.2 Angita Pharma S-Amlodipine Description and Business Overview
6.12.3 Angita Pharma S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Angita Pharma S-Amlodipine Product Portfolio
6.12.5 Angita Pharma Recent Developments/Updates
6.13 Florida DOH Central Pharmacy
6.13.1 Florida DOH Central Pharmacy Corporation Information
6.13.2 Florida DOH Central Pharmacy S-Amlodipine Description and Business Overview
6.13.3 Florida DOH Central Pharmacy S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Florida DOH Central Pharmacy S-Amlodipine Product Portfolio
6.13.5 Florida DOH Central Pharmacy Recent Developments/Updates
6.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
6.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Corporation Information
6.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Description and Business Overview
6.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Portfolio
6.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.15 Yangzijiang Pharmaceutical
6.15.1 Yangzijiang Pharmaceutical Corporation Information
6.15.2 Yangzijiang Pharmaceutical S-Amlodipine Description and Business Overview
6.15.3 Yangzijiang Pharmaceutical S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Yangzijiang Pharmaceutical S-Amlodipine Product Portfolio
6.15.5 Yangzijiang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 S-Amlodipine Industry Chain Analysis
7.2 S-Amlodipine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 S-Amlodipine Production Mode & Process
7.4 S-Amlodipine Sales and Marketing
7.4.1 S-Amlodipine Sales Channels
7.4.2 S-Amlodipine Distributors
7.5 S-Amlodipine Customers
8 S-Amlodipine Market Dynamics
8.1 S-Amlodipine Industry Trends
8.2 S-Amlodipine Market Drivers
8.3 S-Amlodipine Market Challenges
8.4 S-Amlodipine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global S-Amlodipine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global S-Amlodipine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global S-Amlodipine Market Competitive Situation by Manufacturers in 2024
Table 4. Global S-Amlodipine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global S-Amlodipine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global S-Amlodipine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global S-Amlodipine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market S-Amlodipine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of S-Amlodipine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of S-Amlodipine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of S-Amlodipine, Product Type & Application
Table 12. Global Key Manufacturers of S-Amlodipine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global S-Amlodipine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in S-Amlodipine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global S-Amlodipine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global S-Amlodipine Sales by Region (2018-2023) & (K Units)
Table 18. Global S-Amlodipine Sales Market Share by Region (2018-2023)
Table 19. Global S-Amlodipine Sales by Region (2024-2034) & (K Units)
Table 20. Global S-Amlodipine Sales Market Share by Region (2024-2034)
Table 21. Global S-Amlodipine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global S-Amlodipine Revenue Market Share by Region (2018-2023)
Table 23. Global S-Amlodipine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global S-Amlodipine Revenue Market Share by Region (2024-2034)
Table 25. North America S-Amlodipine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 27. North America S-Amlodipine Sales by Country (2024-2034) & (K Units)
Table 28. North America S-Amlodipine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America S-Amlodipine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe S-Amlodipine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 32. Europe S-Amlodipine Sales by Country (2024-2034) & (K Units)
Table 33. Europe S-Amlodipine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe S-Amlodipine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific S-Amlodipine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific S-Amlodipine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific S-Amlodipine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific S-Amlodipine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific S-Amlodipine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America S-Amlodipine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America S-Amlodipine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America S-Amlodipine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America S-Amlodipine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa S-Amlodipine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa S-Amlodipine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa S-Amlodipine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa S-Amlodipine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global S-Amlodipine Sales (K Units) by Type (2018-2023)
Table 51. Global S-Amlodipine Sales (K Units) by Type (2024-2034)
Table 52. Global S-Amlodipine Sales Market Share by Type (2018-2023)
Table 53. Global S-Amlodipine Sales Market Share by Type (2024-2034)
Table 54. Global S-Amlodipine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global S-Amlodipine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global S-Amlodipine Revenue Market Share by Type (2018-2023)
Table 57. Global S-Amlodipine Revenue Market Share by Type (2024-2034)
Table 58. Global S-Amlodipine Price (US$/Unit) by Type (2018-2023)
Table 59. Global S-Amlodipine Price (US$/Unit) by Type (2024-2034)
Table 60. Global S-Amlodipine Sales (K Units) by Application (2018-2023)
Table 61. Global S-Amlodipine Sales (K Units) by Application (2024-2034)
Table 62. Global S-Amlodipine Sales Market Share by Application (2018-2023)
Table 63. Global S-Amlodipine Sales Market Share by Application (2024-2034)
Table 64. Global S-Amlodipine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global S-Amlodipine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global S-Amlodipine Revenue Market Share by Application (2018-2023)
Table 67. Global S-Amlodipine Revenue Market Share by Application (2024-2034)
Table 68. Global S-Amlodipine Price (US$/Unit) by Application (2018-2023)
Table 69. Global S-Amlodipine Price (US$/Unit) by Application (2024-2034)
Table 70. Aristo Pharmaceuticals Pvt Ltd Corporation Information
Table 71. Aristo Pharmaceuticals Pvt Ltd Description and Business Overview
Table 72. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product
Table 74. Aristo Pharmaceuticals Pvt Ltd Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Novartis S-Amlodipine Product
Table 79. Novartis Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Pfizer S-Amlodipine Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Lek Corporation Information
Table 86. Lek Description and Business Overview
Table 87. Lek S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Lek S-Amlodipine Product
Table 89. Lek Recent Developments/Updates
Table 90. TEVA Corporation Information
Table 91. TEVA Description and Business Overview
Table 92. TEVA S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. TEVA S-Amlodipine Product
Table 94. TEVA Recent Developments/Updates
Table 95. Macleods Pharmaceuticals Corporation Information
Table 96. Macleods Pharmaceuticals Description and Business Overview
Table 97. Macleods Pharmaceuticals S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Macleods Pharmaceuticals S-Amlodipine Product
Table 99. Macleods Pharmaceuticals Recent Developments/Updates
Table 100. Caraco Pharmaceutical Corporation Information
Table 101. Caraco Pharmaceutical Description and Business Overview
Table 102. Caraco Pharmaceutical S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Caraco Pharmaceutical S-Amlodipine Product
Table 104. Caraco Pharmaceutical Recent Developments/Updates
Table 105. Sanis Health Corporation Information
Table 106. Sanis Health Description and Business Overview
Table 107. Sanis Health S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Sanis Health S-Amlodipine Product
Table 109. Sanis Health Recent Developments/Updates
Table 110. Jamp Pharma Corporation Information
Table 111. Jamp Pharma Description and Business Overview
Table 112. Jamp Pharma S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Jamp Pharma S-Amlodipine Product
Table 114. Jamp Pharma Recent Developments/Updates
Table 115. Accel Pharma Corporation Information
Table 116. Accel Pharma Description and Business Overview
Table 117. Accel Pharma S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Accel Pharma S-Amlodipine Product
Table 119. Accel Pharma Recent Developments/Updates
Table 120. Jubilant Generics Corporation Information
Table 121. Jubilant Generics Description and Business Overview
Table 122. Jubilant Generics S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Jubilant Generics S-Amlodipine Product
Table 124. Jubilant Generics Recent Developments/Updates
Table 125. Angita Pharma Corporation Information
Table 126. Angita Pharma Description and Business Overview
Table 127. Angita Pharma S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Angita Pharma S-Amlodipine Product
Table 129. Angita Pharma Recent Developments/Updates
Table 130. Florida DOH Central Pharmacy Corporation Information
Table 131. Florida DOH Central Pharmacy Description and Business Overview
Table 132. Florida DOH Central Pharmacy S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Florida DOH Central Pharmacy S-Amlodipine Product
Table 134. Florida DOH Central Pharmacy Recent Developments/Updates
Table 135. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Corporation Information
Table 136. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 137. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product
Table 139. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 140. Yangzijiang Pharmaceutical Corporation Information
Table 141. Yangzijiang Pharmaceutical Description and Business Overview
Table 142. Yangzijiang Pharmaceutical S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Yangzijiang Pharmaceutical S-Amlodipine Product
Table 144. Yangzijiang Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. S-Amlodipine Distributors List
Table 148. S-Amlodipine Customers List
Table 149. S-Amlodipine Market Trends
Table 150. S-Amlodipine Market Drivers
Table 151. S-Amlodipine Market Challenges
Table 152. S-Amlodipine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of S-Amlodipine
Figure 2. Global S-Amlodipine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global S-Amlodipine Market Share by Type in 2024 & 2034
Figure 4. Amlodipine Besylate Tablets Product Picture
Figure 5. Amlodipine Mesylate Tablets Product Picture
Figure 6. Amlodipine Maleate Tablets Product Picture
Figure 7. Global S-Amlodipine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global S-Amlodipine Market Share by Application in 2024 & 2034
Figure 9. Hypertension
Figure 10. Angina pectoris
Figure 11. Global S-Amlodipine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global S-Amlodipine Market Size (2018-2034) & (US$ Million)
Figure 13. Global S-Amlodipine Sales (2018-2034) & (K Units)
Figure 14. Global S-Amlodipine Average Price (US$/Unit) & (2018-2034)
Figure 15. S-Amlodipine Report Years Considered
Figure 16. S-Amlodipine Sales Share by Manufacturers in 2024
Figure 17. Global S-Amlodipine Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest S-Amlodipine Players: Market Share by Revenue in 2024
Figure 19. S-Amlodipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global S-Amlodipine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America S-Amlodipine Sales Market Share by Country (2018-2034)
Figure 22. North America S-Amlodipine Revenue Market Share by Country (2018-2034)
Figure 23. United States S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe S-Amlodipine Sales Market Share by Country (2018-2034)
Figure 26. Europe S-Amlodipine Revenue Market Share by Country (2018-2034)
Figure 27. Germany S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific S-Amlodipine Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific S-Amlodipine Revenue Market Share by Region (2018-2034)
Figure 34. China S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Southeast Asia S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Latin America S-Amlodipine Sales Market Share by Country (2018-2034)
Figure 42. Latin America S-Amlodipine Revenue Market Share by Country (2018-2034)
Figure 43. Mexico S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Brazil S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Argentina S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Colombia S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa S-Amlodipine Sales Market Share by Country (2018-2034)
Figure 48. Middle East & Africa S-Amlodipine Revenue Market Share by Country (2018-2034)
Figure 49. Turkey S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Saudi Arabia S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. UAE S-Amlodipine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Global Sales Market Share of S-Amlodipine by Type (2018-2034)
Figure 53. Global Revenue Market Share of S-Amlodipine by Type (2018-2034)
Figure 54. Global S-Amlodipine Price (US$/Unit) by Type (2018-2034)
Figure 55. Global Sales Market Share of S-Amlodipine by Application (2018-2034)
Figure 56. Global Revenue Market Share of S-Amlodipine by Application (2018-2034)
Figure 57. Global S-Amlodipine Price (US$/Unit) by Application (2018-2034)
Figure 58. S-Amlodipine Value Chain
Figure 59. S-Amlodipine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed